Filing Details

Accession Number:
0001209191-18-054560
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-10-09 17:13:24
Reporting Period:
2018-10-05
Accepted Time:
2018-10-09 17:13:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1294133 Inogen Inc INGN Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1596385 Heath Lukatch C/O Inogen, Inc.
326 Bollay Drive
Goleta CA 93117
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-10-05 500 $43.21 1,489 No 4 M Direct
Common Stock Disposition 2018-10-05 40 $214.34 1,449 No 4 S Direct
Common Stock Disposition 2018-10-05 40 $215.28 1,409 No 4 S Direct
Common Stock Disposition 2018-10-05 20 $216.49 1,389 No 4 S Direct
Common Stock Disposition 2018-10-05 260 $218.85 1,129 No 4 S Direct
Common Stock Disposition 2018-10-05 130 $219.17 999 No 4 S Direct
Common Stock Disposition 2018-10-05 10 $220.56 989 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-10-05 500 $0.00 500 $43.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,165 2022-10-13 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018.
  2. Represents the weighted average share price of an aggregate total of 40 shares sold in the price range of $214.00 to $214.68 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. Represents the weighted average share price of an aggregate total of 40 shares sold in the price range of $215.00 to $215.55 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. Represents the weighted average share price of an aggregate total of 20 shares sold in the price range of $216.03 to $216.95 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. Represents the weighted average share price of an aggregate total of 260 shares sold in the price range of $218.10 to $219.04 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  6. Represents the weighted average share price of an aggregate total of 130 shares sold in the price range of $219.10 to $219.73 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  7. Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan), 1/12th of the total shares subject to the option vested monthly, beginning with the first month anniversary after the vesting commencement date, but vested fully on the date of the 2016 Annual Meeting of the Issuer's stockholders held after the vesting commencement date. The vesting commencement date for this option was October 14, 2015.